To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 1 March 2022 to Question 100420, on Coronavirus: Immune Thrombocytopenic Purpura, if he will publish the evidence relied upon in reaching the determination that an association between the AstraZeneca covid-19 vaccine and TTS was likely.
This answer is the replacement for a previous holding answer.
Answered on
28 April 2022
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Answered by
Department of Health and Social Care
Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.